healthcare
healthcare Articles
Spectrum Pharmaceuticals on Thursday after the firm announced that it would be selling its portfolio of seven FDA-approved hematology/oncology products to Acrotech Biopharma.
Published:
Last Updated:
Aptinyx shares were absolutely crushed on Wednesday after the firm reported midstage results from its clinical study in patients with painful diabetic peripheral neuropathy.
Published:
Last Updated:
CVS shares dipped on Tuesday after the company announced that it would be parting ways with the megastore Walmart.
Published:
Last Updated:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
The December 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Akorn shares dipped on Wednesday after the company received a warning letter from the FDA regarding its Decatur, Illinois, manufacturing facility.
Published:
Last Updated:
The world of legalized marijuana and cannabis sales is expected to keep growing, and a new 2019 forecast projects even stronger growth.
Published:
Last Updated:
Moderna shares made a handy gain early Tuesday after the company announced updates to several of its immuno-oncology and rare disease programs and outlined its 2019–2020 corporate objectives.
Published:
Last Updated:
Clinical-stage biopharmaceutical company Alector has filed with the SEC for its initial public offering.
Published:
Last Updated:
Loxo shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly. The transaction is not subject to any financing condition and is expected to close by...
Published:
Last Updated:
Axsome shares absolutely exploded on Monday after the company announced that its midstage trial in patients with major depressive disorder met its primary endpoint.
Published:
Last Updated:
Clinical-stage biopharmaceutical company Poseida Therapeutics has filed with the SEC regarding its initial public offering.
Published:
Last Updated:
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the first quarter of 2019.
Published:
Last Updated:
Ultragenyx Pharma shares made a handy gain to close out the week after the company announced positive results from its midstage trial for the treatment of glycogen storage disease type Ia.
Published:
Last Updated:
Selecta Biosciences shares pushed higher on Friday after the company provided an update on its new streamlined structure under its new president and CEO.
Published:
Last Updated: